Artivion

Kennesaw, United States Founded: 1984 • Age: 42 yrs Listed
Aortic and cardiac surgical solutions and vascular allografts are manufactured.

About Artivion

Artivion is a publicly listed company based in Kennesaw (United States) founded in 1984. Aortic and cardiac surgical solutions and vascular allografts are manufactured. The company has 1,600 employees. Artivion has completed 1 acquisition, including Endospan. Its chief executive, as recorded, is J Patrick Mackin. Its website artivion.com draws about 23 thousand monthly visits. Artivion offers products and services including AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve. Its focus areas include Traditional Medical Devices. Its legal entity is Artivion, Inc.

Company details

Artivion was founded in 1984 and is headquartered in Kennesaw, United States. Operations center on the medical device sector, where technologies for aortic diseases are developed and supplied. Products include aortic arch stent graft systems, hybrid prostheses, heart valves, surgical sealants and adhesives, cardiac and vascular allografts, and decellularized bovine pericardium. Solutions are provided to cardiac and vascular surgeons for treating patients with aortic conditions.

  • Headquarters Kennesaw, United States
  • Employees 1,600
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website artivion.com
  • Social LinkedIn Facebook YouTube
  • Legal Name Artivion, Inc.
Key Metrics
  • Annual Revenue
    $441.33 M (USD)
    13.59
    as on Dec 31, 2025
  • Net Profit
    $9.76 M (USD)
    as on Dec 31, 2025
  • EBITDA
    $56.64 M (USD)
    9.58
    as on Dec 31, 2025
  • Latest Funding Round
    $250M (USD), Debt – Conventional

    Jan 2024

  • Investors
  • Employee Count
    1,600
  • Investments & Acquisitions

Products & Services of Artivion

Artivion offers a comprehensive portfolio of products and services, including AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve.

AMDS Hybrid Prosthesis
Aortic Devices

This device is utilized for treating acute aortic dissections and is recognized as the first aortic arch remodeling tool

ON-X Aortic Heart Valve
Heart Valves

This valve is employed in surgical procedures to replace damaged heart valves and improve patient outcomes

Apps and channels of Artivion

its YouTube channel Artivion, Inc. has 11 subscribers and 30 videos.

Artivion, Inc.
YouTube 11 subscribers 30 videos Autos & Vehicles
Open channel

Videos from Artivion

The most watched videos on Artivion's YouTube channel, Artivion, Inc. (11 subscribers). Click a video to play it here.

We Are Artivion, Inc.
2.6K views
Patient Success Story: Ian Craven, Out of the Blue
1.1K views
BioGlue Product Animation
149 views
Artivion's Clinical Power at EACTS 2024
103 views

More on Artivion, Inc..

Funding Insights of Artivion

  • Total Rounds 4
  • Last Round Debt – Conventional β€” $250M
  • First Round $1.25M

    (Oct 2010)

  • Investors Count 2

All 4 funding rounds of Artivion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2024$250MDebt – Conventional––
Jun 2020$100MPost-IPO––
–
Sep 2011Grant––
Oct 2010$1.25MPost-IPO––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Artivion

Artivion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ares Management and Military Health.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Alternative asset investment management firm
1997aresmgmt.comLos Angeles, United States
Administers health care and support for military personnel and operations.
health.mil
Premium access

Investor details for Artivion

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Artivion

3 people are tracked at Artivion (3 in leadership); the tracked headcount is 1,600.

NameRoleGroup
Florian Tyrs
Managing DirectorLeadership
J Patrick Mackin
CEOLeadership
Elizabeth A. Hoff
Consultant And FounderLeadership
Premium access

Complete people profiles for Artivion

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Artivion

Artivion is a publicly listed company on the NYSE with ticker symbol AORT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date12 Feb 1993
  • Listed onNYSE: AORT
  • Listed entityArtivion, Inc.
  • Exchange sectorHealth technology
  • ISINUS2289031005
  • Share price$21.36 (-1.97% on the day) · 2026-10-13
  • Market capitalisation$1.04B
  • EPS (diluted, trailing year)$-0.07
  • Volume (last session)664,563

Financials of Artivion

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$441.3M$9.8M$56.6M
2024$388.5M-$13.3M$51.7M
2023$354.0M-$30.6M$37.9M
2022$313.8M-$19.1M$37.4M
2021$298.8M-$14.7M$30.3M
Premium access

Detailed financial statements for Artivion

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Artivion

Artivion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Endospan.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Endovascular stent graft systems for aortic aneurysm repair are developed.
endospan.comHerzliya, Israel2009May 2026β€’β€’β€’β€’
Premium access

Complete acquisition details for Artivion

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Artivion

5 dated milestones of Artivion across 42 years, from founding to its latest funding, stage changes and deals.

  1. Founded Artivion is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $1.2M.
  4. Funding Latest funding round, Debt – Conventional, of $250.0M.
  5. Acquisition Acquires Endospan.

Web traffic of Artivion

The website of Artivion (artivion.com) receives about 22.8K visits a month.

  • Monthly visits
    22.8K

    ▲ 20.3% vs previous month

Similar websites

Websites whose visitors overlap most with Artivion. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jotec.com
100%
3.5K#4,186,229View details
icaavcr.com
icaavcr.com
22%
–

Top companies in Traditional Diagnostics & Medical Devices

3 companies that operate in the same segment as Artivion (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Materials management solutions are provided for healthcare organizations.
1892Chicago, Illinois, United StatesUSD 29.13 MUSD 19.48 B95,424
3D-printed orthopedic products are manufactured for medical applications.
1941Kalamazoo, Michigan, United States
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Artivion

Premium access

Complete news archive for Artivion

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Artivion

Artivion was founded in 1984 and raised its 1st funding round 26 years after it was founded.

Artivion is headquartered in Kennesaw, United States. It is registered at Kennesaw, Georgia, United States.

J Patrick Mackin is the CEO of Artivion, as recorded in our data.

Artivion has 1,600 employees.

Annual revenue of Artivion is $441.33M as on Dec 31, 2025.

Artivion was founded in 1984 and is headquartered in Kennesaw, United States. Operations center on the medical device sector, where technologies for aortic diseases are developed and supplied. Products include aortic arch stent graft systems, hybrid prostheses, heart valves, surgical sealants and adhesives, cardiac and vascular allografts, and decellularized bovine pericardium. Solutions are provided to cardiac and vascular surgeons for treating patients with aortic conditions.

Artivion offers AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve.

Yes, Artivion is publicly traded on NYSE under the ticker symbol AORT.

Artivion has made 1 acquisition, including Endospan.

Artivion has 2 investors. Key investors include Ares Management, and Military Health.

Artivion operates through Artivion, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available